All About Multiple Sclerosis

More MS news articles for February 2003

Clinical Trials Update: Feb. 19, 2003

Wed Feb 19,11:55 PM ET

Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Sclerosis

A 13-month clinical research study of the use of IGIV (Intravenous Immunoglobulin-Chromatogrpahy) in Multiple Sclerosis. IGIV is currently used for treatment of MS, but has not been approved by the U.S. Food and Drug Administration (news - web sites). Males and females 18-55 with relapsing remitting MS may be eligible to participate. Research site located in New York, New York.

More Information

Please see

© Copyright 2003 CenterWatch